Ferreri K, Talavera F, Menon K M
Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor 48109-0278.
Endocrinology. 1992 Nov;131(5):2059-64. doi: 10.1210/endo.131.5.1330487.
Rat luteal cells preferentially utilize cholesterol derived from high density lipoproteins (HDL) as a substrate for steroid hormone synthesis. The uptake of cholesterol from HDL by these cells is in contrast to nonsteroidogenic cells, which export cholesterol to HDL. A previous study demonstrated that HDL binding to luteal cell membranes was increased in conjunction with in vivo cholesterol depletion or cholesterol loading of the ovary induced by pharmacological agents. These results suggest a biphasic regulation of the HDL receptor in luteinized rat ovaries. In the present studies, the in vitro regulation of HDL binding in rat luteal cells by increased intracellular cholesterol was examined. Cultured luteal cells were incubated with increasing doses of low density lipoproteins (LDL) for 2 days after which the cellular sterol content and the effects on progesterone production and HDL binding were measured. As expected, the LDL treatment increased total cellular sterol content in a dose-dependent manner, resulting in a 2.1-fold increase over control at a dose of 1 mg LDL/ml. Increased cellular cholesterol was accompanied by a comparable increase in progesterone secretion. These results suggest that exogenous cholesterol was utilized by these cells. The LDL treatment also increased the binding of HDL to the cells in a dose-dependent manner to a maximum of 2.2-fold over control. The effect of increased cellular sterol on HDL binding was also examined using a more polar cholesterol derivative, 25-hydroxycholesterol. Cells were cultured for 2 days in media containing 0.3-40 micrograms/ml 25-hydroxycholesterol in the presence of 100 micrograms/ml aminoglutethimide, an inhibitor of cholesterol metabolism. The HDL binding to luteal cells exhibited dose-dependent up-regulation by 25-hydroxycholesterol with a 5.8-fold increase in binding at the maximum dose tested. Equilibrium binding studies using cells treated with 10 micrograms/ml 25-hydroxycholesterol revealed a 2.1-fold increase in the number of HDL binding sites on the luteal cells without affecting the binding affinity. From the results of this study, it is concluded that HDL binding in rat luteal cells is up-regulated by an increase in the intracellular cholesterol level.
大鼠黄体细胞优先利用来源于高密度脂蛋白(HDL)的胆固醇作为类固醇激素合成的底物。这些细胞从HDL摄取胆固醇,这与非类固醇生成细胞相反,后者将胆固醇输出到HDL。先前的一项研究表明,随着体内胆固醇消耗或药物诱导的卵巢胆固醇负荷增加,HDL与黄体细胞膜的结合也会增加。这些结果提示了黄体化大鼠卵巢中HDL受体的双相调节。在本研究中,检测了细胞内胆固醇增加对大鼠黄体细胞中HDL结合的体外调节作用。将培养的黄体细胞与递增剂量的低密度脂蛋白(LDL)孵育2天,之后测量细胞固醇含量以及对孕酮产生和HDL结合的影响。正如预期的那样,LDL处理以剂量依赖的方式增加了细胞总固醇含量,在1mg LDL/ml的剂量下比对照增加了2.1倍。细胞胆固醇增加伴随着孕酮分泌的相应增加。这些结果表明这些细胞利用了外源性胆固醇。LDL处理还以剂量依赖的方式增加了HDL与细胞的结合,最高比对照增加了2.2倍。还使用一种极性更强的胆固醇衍生物25-羟胆固醇检测了细胞固醇增加对HDL结合的影响。在存在100μg/ml氨鲁米特(一种胆固醇代谢抑制剂)的情况下,将细胞在含有0.3 - 40μg/ml 25-羟胆固醇的培养基中培养2天。25-羟胆固醇对黄体细胞的HDL结合表现出剂量依赖性上调,在测试的最大剂量下结合增加了5.8倍。使用用10μg/ml 25-羟胆固醇处理的细胞进行的平衡结合研究显示,黄体细胞上HDL结合位点的数量增加了2.1倍,而不影响结合亲和力。从本研究结果得出结论,大鼠黄体细胞中的HDL结合通过细胞内胆固醇水平的增加而上调。